Production (Stage)
Silence Therapeutics plc
SLN
$5.19
$0.193.80%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 136.53M | 147.33M | 172.89M | 189.06M | 192.92M |
Total Receivables | 16.84M | 26.91M | 22.19M | 18.37M | 23.78M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | 13.12M | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 16.42M | -- | 16.03M | 15.47M | 12.82M |
Total Current Assets | 169.79M | 187.37M | 211.11M | 222.90M | 229.52M |
|
|||||
Total Current Assets | 169.79M | 187.37M | 211.11M | 222.90M | 229.52M |
Net Property, Plant & Equipment | 1.80M | 1.98M | 2.21M | 2.13M | 2.26M |
Long-term Investments | 9.78M | 9.39M | 10.10M | 9.68M | 9.76M |
Goodwill | 9.78M | 9.39M | 10.10M | 9.68M | 9.76M |
Total Other Intangibles | 310.00K | 312.00K | 345.80K | 337.40K | 347.30K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 3.61M | 3.59M | 2.87M | 2.98M | 3.24M |
Total Assets | 185.30M | 202.64M | 227.02M | 238.40M | 245.50M |
|
|||||
Total Accounts Payable | 18.81M | 3.70M | 19.13M | 18.95M | 13.24M |
Total Accrued Expenses | -- | 12.05M | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 60.00K | 117.00K | 186.30K | 232.50K | 232.40K |
Total Finance Division Other Current Liabilities | 392.00K | 958.00K | 3.35M | 3.50M | 4.43M |
Total Other Current Liabilities | 392.00K | 958.00K | 3.35M | 3.50M | 4.43M |
Total Current Liabilities | 19.26M | 16.82M | 22.67M | 22.67M | 17.90M |
|
|||||
Total Current Liabilities | 19.26M | 16.82M | 22.67M | 22.67M | 17.90M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | 117.50K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 53.29M | 51.79M | 77.68M | 73.54M | 70.99M |
Total Liabilities | 72.56M | 68.61M | 100.35M | 96.21M | 89.01M |
|
|||||
Common Stock & APIC | 623.36M | 619.85M | 495.80M | 459.89M | 458.40M |
Retained Earnings | -510.62M | -485.83M | -464.61M | -404.60M | -386.10M |
Treasury Stock & Other | -- | -- | 95.50M | 86.90M | 84.18M |
Total Common Equity | 112.74M | 134.02M | 126.68M | 142.19M | 156.49M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 112.74M | 134.02M | 126.68M | 142.19M | 156.49M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 112.74M | 134.02M | 126.68M | 142.19M | 156.49M |
|